ES2009368A6 - Enziomoinmunoensayo para detectar antigenos de hiv en suero humano. - Google Patents

Enziomoinmunoensayo para detectar antigenos de hiv en suero humano.

Info

Publication number
ES2009368A6
ES2009368A6 ES8803361A ES8803361A ES2009368A6 ES 2009368 A6 ES2009368 A6 ES 2009368A6 ES 8803361 A ES8803361 A ES 8803361A ES 8803361 A ES8803361 A ES 8803361A ES 2009368 A6 ES2009368 A6 ES 2009368A6
Authority
ES
Spain
Prior art keywords
immuno assay
enziomo
human serum
hiv antigens
hiv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES8803361A
Other languages
English (en)
Inventor
Kenneth H Kortight
Meryl Ann Forman
Paulette E Smariga
David E Hofheinz
Song Yea Lee
Candie Sue Stoner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Coulter Corp
Original Assignee
Coulter Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22376766&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2009368(A6) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Coulter Corp filed Critical Coulter Corp
Publication of ES2009368A6 publication Critical patent/ES2009368A6/es
Expired legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/112—Retroviridae (F), e.g. leukemia viruses
    • C07K16/114—Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]
    • C07K16/1143—Gag-pol proteins, e.g. p17or p24
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/974—Aids related test
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/80—Fluorescent dyes, e.g. rhodamine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/805—Optical property
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808—Automated or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/809—Multifield plates or multicontainer arrays
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/825—Pretreatment for removal of interfering factors from sample
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/826—Additives, e.g. buffers, diluents, preservatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

SE PROPORCIONA UN INMUNOENSAYO EN FASE SOLIDA PARA LA DETERMINACION DE ANTIGENOS DE HIV EN FLUIDOS FISIOLOGICOS HUMANOS. EL INMUNOENSAYO SE CARACTERIZA POR RECUBRIR UN SUSTRATO SOLIDO CON UN ANTICUERPO MONOCLONAL UNICO QUE RECONOCE A UN DETERMINANTE ANTIGENICO COMUN A UN GRUPO DE ANTIGENOS DEL NUCLEO DE HIV Y A NINGUN ANTIGENO DE LA ENVOLTURA DE HIV. LA MUESTRA A ENSAYAR TAMBIEN SE SOMETE PREFERIBLEMENTE A UN REACTIVO LISTANTE ANTES DE LA INCUBACION PARA DISPERSAR UNIFORMEMENTE LOS ANTIGENOS QUE PUDIERA HABER PRESENTES EN LA MUESTRA A ENSAYAR.
ES8803361A 1987-11-06 1988-11-04 Enziomoinmunoensayo para detectar antigenos de hiv en suero humano. Expired ES2009368A6 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/118,149 US4886742A (en) 1987-06-15 1987-11-06 Enzyme immunoassay for detecting HIV antigens in human sera

Publications (1)

Publication Number Publication Date
ES2009368A6 true ES2009368A6 (es) 1989-09-16

Family

ID=22376766

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8803361A Expired ES2009368A6 (es) 1987-11-06 1988-11-04 Enziomoinmunoensayo para detectar antigenos de hiv en suero humano.

Country Status (13)

Country Link
US (1) US4886742A (es)
EP (1) EP0386136B1 (es)
JP (1) JPH03502241A (es)
KR (1) KR890702038A (es)
CN (1) CN1021375C (es)
CA (1) CA1337264C (es)
DE (1) DE3853430T2 (es)
ES (1) ES2009368A6 (es)
IE (1) IE61407B1 (es)
IL (1) IL88248A (es)
MX (1) MX168290B (es)
WO (1) WO1989004488A1 (es)
ZA (1) ZA888170B (es)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5215913A (en) * 1987-11-30 1993-06-01 Roger Williams General Hospital IgG-1 human monoclonal antibody reactive with an HIV-1 antigen and methods of use
US5149623A (en) * 1988-02-09 1992-09-22 Virotest, Inc. Rapid, easy, and economical screening test for antibodies to human immunodeficiency virus
US5108891A (en) * 1988-06-09 1992-04-28 Beth Israel Medical Center Aids assay
US5210181A (en) * 1989-05-15 1993-05-11 Akzo N.V. T-lymphotropic retrovirus peptide
ATE126238T1 (de) * 1990-06-01 1995-08-15 Lepetit Spa Monoklonale antikörper gegen gag-protein- vorläufer-p55 von hiv-virus.
US5667964A (en) * 1994-10-28 1997-09-16 Cornell Research Foundation, Inc. Rapid, direct, and qualitative method for the determination of the number of HIV-1-infected patient cells employing reactive oxygen intermediate generators
US5756352A (en) * 1995-06-07 1998-05-26 Gen-Probe Incorporated Thiocationic lipid-nucleic acid conjugates
US5759519A (en) * 1995-06-07 1998-06-02 Gen-Probe Incorporated Method for the intracellular delivery of biomolecules using thiocationic lipids
US5851548A (en) * 1995-06-07 1998-12-22 Gen-Probe Incorporated Liposomes containing cationic lipids and vitamin D
US5711964A (en) * 1995-06-07 1998-01-27 United States Of America Method for the intracellular delivery of biomolecules using liposomes containing cationic lipids and vitamin D
US5739271A (en) * 1995-06-07 1998-04-14 Gen-Probe Incorporated Thiocationic lipids
DE19539574A1 (de) * 1995-10-25 1997-04-30 Boehringer Mannheim Gmbh Zubereitungen und Verfahren zur Stabilisierung biologischer Materialien mittels Trocknungsverfahren ohne Einfrieren
US6265184B1 (en) 1995-12-20 2001-07-24 Icos Corporation Polynucleotides encoding chemokine receptor 88C
US5925514A (en) * 1996-12-10 1999-07-20 The Regents Of The University Of California Apparatus for testing for infection by a retrovirus
US5841975A (en) * 1996-12-10 1998-11-24 The Regents Of The University Of California Method and apparatus for globally-accessible automated testing
US5968731A (en) * 1996-12-10 1999-10-19 The Regents Of The University Of California Apparatus for automated testing of biological specimens
US6818392B2 (en) 2000-12-06 2004-11-16 Abbott Laboratories Monoclonal antibodies to human immunodeficiency virus and uses thereof
US7387890B2 (en) 2004-12-16 2008-06-17 Chembio Diagnostic Systems, Inc. Immunoassay devices and use thereof
WO2006098804A2 (en) 2005-03-11 2006-09-21 Chembio Diagnostic Systems, Inc. Dual path immunoassay device
US7189522B2 (en) 2005-03-11 2007-03-13 Chembio Diagnostic Systems, Inc. Dual path immunoassay device
US20100022916A1 (en) 2008-07-24 2010-01-28 Javanbakhsh Esfandiari Method and Apparatus for Collecting and Preparing Biological Samples for Testing
AU2011230619C1 (en) 2010-03-25 2016-06-23 Oregon Health & Science University CMV glycoproteins and recombinant vectors
US8603835B2 (en) 2011-02-10 2013-12-10 Chembio Diagnostic Systems, Inc. Reduced step dual path immunoassay device and method
HUE037408T2 (hu) 2011-06-10 2018-08-28 Univ Oregon Health & Science CMV glikoproteinek és rekombináns vektorok
CA2789539A1 (en) 2011-09-12 2013-03-12 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
US9402894B2 (en) 2011-10-27 2016-08-02 International Aids Vaccine Initiative Viral particles derived from an enveloped virus
ES2631608T3 (es) 2012-06-27 2017-09-01 International Aids Vaccine Initiative Variante de la glicoproteína Env del VIH-1
EP2848937A1 (en) 2013-09-05 2015-03-18 International Aids Vaccine Initiative Methods of identifying novel HIV-1 immunogens
US10058604B2 (en) 2013-10-07 2018-08-28 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
SG11201608278WA (en) 2014-04-02 2016-10-28 Chembio Diagnostic Systems Inc Immunoassay utilizing trapping conjugate
US20160116466A1 (en) 2014-10-27 2016-04-28 Chembio Diagnostic Systems, Inc. Rapid Screening Assay for Qualitative Detection of Multiple Febrile Illnesses
EP3069730A3 (en) 2015-03-20 2017-03-15 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
US9931394B2 (en) 2015-03-23 2018-04-03 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
US9874499B1 (en) 2015-04-23 2018-01-23 Boaz Lerer Method of sample preparation for epidermal nerve fiber density testing
US9925258B2 (en) 2015-10-02 2018-03-27 International Aids Vaccine Initiative Replication-competent VSV-HIV Env vaccines
CN112285346B (zh) * 2020-07-25 2024-02-13 四川大学华西医院 基于量子点选择性阳离子交换反应的HIV p24高灵敏检测方法
CN116897203A (zh) * 2021-02-12 2023-10-17 美国西门子医学诊断股份有限公司 样品裂解试剂组合物及其生产和使用方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA855031B (en) * 1984-08-31 1986-02-26 New York Blood Center Inc Assay for simultaneous detection of antigen and antibody in given serum
US4755457A (en) * 1985-02-05 1988-07-05 Robert Guroff Marjorie Method for detecting HTLV-III neutralizing antibodies in sera
US4748110A (en) * 1985-09-25 1988-05-31 Abbott Laboratories Immunoassay for HTLV-III antigens
US4888290A (en) * 1987-11-06 1989-12-19 Coulter Corporation Monoclonal antibody specific to HIV antigens

Also Published As

Publication number Publication date
MX168290B (es) 1993-05-14
WO1989004488A1 (en) 1989-05-18
CA1337264C (en) 1995-10-10
IL88248A0 (en) 1989-06-30
KR890702038A (ko) 1989-12-22
JPH03502241A (ja) 1991-05-23
DE3853430T2 (de) 1995-10-12
IE61407B1 (en) 1994-11-02
CN1021375C (zh) 1993-06-23
CN1036837A (zh) 1989-11-01
EP0386136B1 (en) 1995-03-22
EP0386136A4 (en) 1991-06-12
IE883225L (en) 1988-05-06
EP0386136A1 (en) 1990-09-12
ZA888170B (en) 1990-07-25
US4886742A (en) 1989-12-12
DE3853430D1 (de) 1995-04-27
IL88248A (en) 1993-03-15

Similar Documents

Publication Publication Date Title
ES2009368A6 (es) Enziomoinmunoensayo para detectar antigenos de hiv en suero humano.
ES2082777T3 (es) Un metodo para la deteccion de un anti-cuerpo y antigeno en un inmunoensayo.
KR860700046A (ko) HTLV-Ⅲ 단백질의 분리, AIDS와 pre-AIDS 증상환자 혈청중의 HTLV-Ⅲ에 대한 항체의 혈청학적 검출 및 HTLV-Ⅲ과 이것의 단백질을 사용하는 면역 분석에 의한 HTLV-Ⅲ감염의 검사
ES483313A1 (es) Procedimiento de determinacion inmunologico para un complejoinmunologico
KR890701769A (ko) 인체내 항원 및 또는 항체를 검출하기 위한 동시효소 면역 분석법
ES2065935T3 (es) Anticuerpos monoclonales de raton para hiv-i p24 y su uso en ensayos de diagnostico.
ES8700441A1 (es) Metodo de diagnostico de enfermedades y perfeccionamientos en los sistemas de ensayo de sueros
ES557705A0 (es) Dispositivo para determinacion de una substancia presente en una muestra
JPH01150856A (ja) 抗原および抗体の同時免疫定量法
DE3265768D1 (en) A method and a kit for the assay of antibodies to soluble antigens
SE8200978L (sv) Forfarande och medel for immunologisk analys
ATE135466T1 (de) Durch silber intensiviertes, auf goldmarkierung beruhendes immuntestverfahren
DE3854553D1 (de) Verfahren zum schnellen und empfindlichen Nachweis von IgM-Antikörpern gegen retrovirale Antigene.
ES2059601T3 (es) Un inmunoensayo para la deteccion de anti-hbc en una muestra biologica.
ATE16219T1 (de) Immunologisches latex-agglutinationsverfahren.
ES2141348T3 (es) Metodo de deteccion de la presencia de una especie de mycobacterium, kit y anticuerpos utilizados en este metodo.
GB1549069A (en) Enzyme linked immunoassay
ATE50459T1 (de) Verfahren zur bestimmung einer immunologisch bindefaehigen substanz.
McArthur et al. A rapid micro-method for screening eel sera for antibodies against the digenean Telogaster opisthorchis Macfarlane, 1945.
NO884131L (no) Agglutineringsreagens og dets anvendelse for detektering av et antigen, antistoffer eller andre analytter.
ATE122150T1 (de) Einschritt-immuntest zur bestimmung von antigen- spezifischen antikörpern aller immunglobulin- klassen und dazu geeignetes mittel.
ATE64466T1 (de) Immuntest.
ES2016992B3 (es) Reagente y procedimiento en la determinacion c 3a mediante ensayo inmunoquimico.
Micheel et al. Interspecies antigenic determinants of structural proteins of mammalian type-C viruses as detected by a competitive Sepharose bead immunofluorescence assay
Saluzzo et al. Specific ELISA-IgM antibodies for diagnosis and epidemiological surveillance of flaviviruses in Africa.

Legal Events

Date Code Title Description
SA6 Expiration date (snapshot 920101)

Free format text: 2008-11-04